Niagen Bioscience, Inc. (NAGE)
NASDAQ: NAGE · Real-Time Price · USD
3.430
+0.100 (3.00%)
At close: Jul 2, 2026, 4:00 PM EDT
3.440
+0.010 (0.29%)
After-hours: Jul 2, 2026, 6:49 PM EDT
Niagen Bioscience Employees
Niagen Bioscience had 117 employees as of December 31, 2025. The number of employees increased by 13 or 12.50% compared to the previous year.
Employees
117
Change (1Y)
13
Growth (1Y)
12.50%
Revenue / Employee
$1,114,667
Profits / Employee
$159,291
Market Cap
273.75M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 117 | 13 | 12.50% | 117 | 0 |
| Dec 31, 2024 | 104 | -2 | -1.89% | 104 | 0 |
| Dec 31, 2023 | 106 | -7 | -6.19% | 106 | 0 |
| Dec 31, 2022 | 113 | -2 | -1.74% | 113 | 0 |
| Dec 31, 2021 | 115 | 5 | 4.55% | 115 | 0 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jan 2, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| MacroGenics | 293 |
| Bicycle Therapeutics | 288 |
| ProQR Therapeutics | 187 |
| Entrada Therapeutics | 152 |
| Invivyd | 122 |
| Foghorn Therapeutics | 106 |
| Orchestra BioMed Holdings | 86 |
| Fulcrum Therapeutics | 55 |
NAGE News
- 4 days ago - Niagen Bioscience Registration statement: Registration filing - Filings
- 4 days ago - Niagen Bioscience files $125M mixed securities shelf - TheFly
- 22 days ago - Niagen Bioscience Transcript: 16th Annual East Coast IDEAS Conference - Transcripts
- 4 weeks ago - Niagen Bioscience to Present at the 16th Annual East Coast IDEAS Investor Conference - Business Wire
- 4 weeks ago - Niagen Bioscience renames CERP to Niagen Research Program - TheFly
- 4 weeks ago - Niagen Bioscience Renames ChromaDex External Research Program to the Niagen Research Program, Strengthening Position as the Global Leader in NAD+ Science - Business Wire
- 7 weeks ago - Niagen Bioscience price target lowered to $11 from $12 at H.C. Wainwright - TheFly
- 2 months ago - Niagen Bioscience Announces Participation in Upcoming Investor Conferences - Business Wire